Checkpoint Blockade Therapy Resistance in Hodgkin's Lymphoma

The Lancet - United Kingdom
doi 10.1016/s0140-6736(18)31867-1
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Overcoming Resistance to Checkpoint Blockade Therapy by Targeting PI3Kγ in Myeloid Cells

Nature
Multidisciplinary
2016English

PD-1 Blockade With Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

New England Journal of Medicine
Medicine
2015English

Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

T-Cell Lymphoma Secondary to Checkpoint Inhibitor Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

The COP-BLAM Therapy for Non-Hodgkin's Lymphoma in Elderly Patients.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1990English

Masterful Antibodies: Checkpoint Blockade

Cancer immunology research
Cancer ResearchImmunology
2017English

Immune Checkpoint Blockade in Lymphoid Malignancies

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2016English

Liquid Biopsy in Non‐Hodgkin's Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Resistance Mechanisms in Melanoma to Immuneoncologic Therapy With Checkpoint Inhibitors

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy